GLOBALT Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7M Sell
58,226
-1,191
-2% -$138K 0.25% 52
2025
Q4
$6.25M Sell
59,417
-998
-2% -$93.7K 0.23% 58
2025
Q3
$5.07M Sell
60,415
-638
-1% -$52.5K 0.19% 76
2025
Q2
$4.83M Sell
61,053
-4,382
-7% -$348K 0.19% 72
2025
Q1
$5.87M Sell
65,435
-604
-0.9% -$56.4K 0.24% 62
2024
Q4
$6.57M Sell
66,039
-32,306
-33% -$3.33M 0.25% 50
2024
Q3
$11.2M Sell
98,345
-1,321
-1% -$157K 0.42% 28
2024
Q2
$12.3M Sell
99,666
-2,217
-2% -$286K 0.49% 26
2024
Q1
$13.4M Buy
101,883
+1,185
+1% +$146K 0.54% 26
2023
Q4
$11M Buy
+100,698
New +$10.5M 0.46% 28

Other funds holding MRK

GLOBALT Investments's MRK Position: Q1 2026 in Review

GLOBALT Investments reduced its Merck (MRK) stake by 2% in Q1 2026, selling an estimated $138K and leaving 58,226 shares worth $7M. The position accounts for 0.25% of the portfolio, ranked #52.

GLOBALT Investments first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $13.4M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • GLOBALT Investments held 58,226 shares of Merck worth $7M as of Q1 2026.
  • GLOBALT Investments sold 1,191 Merck shares in Q1 2026, an estimated $138K.
  • Merck made up 0.25% of GLOBALT Investments's portfolio in Q1 2026, its #52 holding.
  • GLOBALT Investments first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • GLOBALT Investments's Merck position peaked at $13.4M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on GLOBALT Investments's 13F filing for Q1 2026, filed 15 May 2026.